Hemafer

Hemafer is an oral iron supplement marketed in the European Union. Its active ingredient is elemental iron, though the specific strength and dosage form are not disclosed. As an over‑the‑counter product, Hemafer is intended to provide the iron needed for normal hemoglobin synthesis and to support individuals with low iron stores. It belongs to the drug class of iron supplements used for iron deficiency anemia.

Hemafer is commonly used to address conditions related to insufficient iron levels.

- Treatment of iron deficiency anemia in adults. - Prevention of iron deficiency in individuals with increased physiological demand, such as menstruating women. - Support for patients recovering from blood loss due to surgery or trauma. - Adjunct therapy for chronic diseases associated with anemia, like chronic kidney disease. - Nutritional supplementation for vegetarians or vegans with low dietary iron intake. - Management of iron deficiency in pregnancy under medical supervision. - Correction of iron deficiency in children with growth monitoring.

Possible side effects of oral iron supplementation such as Hemafer vary in frequency and severity.

Common: - Gastrointestinal discomfort, including nausea or abdominal cramping. - Constipation or loose stools. - Darkening of the stool color. - Metallic taste in the mouth. - Mild heartburn. - Transient loss of appetite. - Mild dizziness. - Temporary increase in bowel sounds. - Mild headache.

Serious: - Severe allergic reaction with rash, itching, swelling, or difficulty breathing. - Significant gastrointestinal bleeding. - Iron overload leading to organ damage (rare with recommended dosing). - Anaphylaxis (extremely rare). - Severe abdominal pain with vomiting. - Persistent vomiting leading to dehydration. - Seizures associated with severe iron toxicity. - Kidney dysfunction in patients with pre-existing renal disease.

When using Hemafer, certain precautions should be observed to minimize risks and ensure safe administration.

- Do not exceed the recommended daily amount without medical advice. - Store the product away from moisture and out of reach of children. - Use caution in individuals with a history of gastrointestinal disorders. - Monitor for signs of iron overload during long‑term use. - Avoid taking Hemafer simultaneously with antacids or calcium supplements that may reduce absorption. - Pregnant or breastfeeding women should consult a healthcare professional before use. - Patients with chronic kidney disease should have iron status evaluated regularly.

Hemafer may interact with certain medications or nutrients, affecting iron absorption or increasing the risk of adverse effects.

Avoid: - Concurrent use of tetracycline antibiotics. - Simultaneous intake of levothyroxine. - Co‑administration with proton pump inhibitors (may reduce absorption). - Iron chelating agents such as deferoxamine. - Methyldopa therapy.

Use with caution: - Antacids containing aluminum, magnesium, or calcium. - Calcium‑rich foods or supplements taken close to dosing. - Certain food dyes or phytates that can bind iron. - High‑dose vitamin C may increase iron absorption, requiring monitoring. - Oral bisphosphonates taken within 2 hours of iron may have reduced efficacy. - Concurrent use of certain diuretics may affect electrolyte balance when combined with iron supplements.